(Q45870681)

17 December 2017

title

Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity (English)

1 reference

17 December 2017

1 reference

Driesse MJ

1

1 reference

17 December 2017

Esandi MC

2

1 reference

17 December 2017

Kros JM

3

1 reference

17 December 2017

Avezaat CJ

4

1 reference

17 December 2017

Vecht C

5

1 reference

17 December 2017

Zurcher C

6

1 reference

17 December 2017

van der Velde I

7

1 reference

17 December 2017

Valerio D

8

1 reference

17 December 2017

Bout A

9

1 reference

17 December 2017

Sillevis Smitt PA

10

1 reference

17 December 2017

publication date

1 August 2000

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

7

1 reference

17 December 2017

issue

16

1 reference

17 December 2017

page(s)

1401-1409

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301250

exact match

0 references

cites work

Tumor cells expressing the herpes simplex virus-thymidine kinase gene in the treatment of Walker 256 meningeal neoplasia in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Treatment of leptomeningeal metastases in a rat model using a recombinant adenovirus containing the HSV-tk gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Distribution of recombinant adenovirus in the cerebrospinal fluid of nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Replication-deficient adenovirus induces expression of interleukin-8 by airway epithelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

A major role for viruses in acute childhood encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Adenoviral vector-mediated gene expression in the nervous system of immunocompetent Wistar and T cell-deficient nude rats: preferential survival of transduced astroglial cells in nude rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Ovalbumin is more immunogenic when introduced into brain or cerebrospinal fluid than into extracerebral sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Afferent and efferent arms of the humoral immune response to CSF-administered albumins in a rat model with normal blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Interleukin 6 enhances a cellular activity that functionally substitutes for E1A protein in transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

7 January 2021

Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

7 January 2021

Adenovirus gene transfer causes inflammation in the brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

7 January 2021

Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

7 January 2021

Delayed-type hypersensitivity response to high doses of adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

7 January 2021

Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

7 January 2021

The immunogenicity of intracerebral virus infection depends on anatomical site.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

7 January 2021

Detection, typing, and subtyping of enteric adenoviruses 40 and 41 from fecal samples and observation of changing incidences of infections with these types and subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301250

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301250

1 reference

17 December 2017

Dimensions Publication ID

1014781692

0 references

1 reference

17 December 2017